Yimiao Biopharma completes IPO counseling and plans to list on the STAR Market

Funding Rounds

▤ Summary

艺妙生物完成了科创板IPO辅导，下一步计划近期提交上市申请。公司成立于2015年，专注于恶性肿瘤基因细胞药物研发。文章同时提到，公司在2025年完成了E轮融资，并引入了国开金融、国投创业等机构。对于关注生命科学与生物医药赛道的读者，这意味着公司正从融资阶段进入资本市场推进阶段。

$ Funding

$
Amount None Total raised
□
Date January 1, 2025 Announcement date
◎
Investors SDIC Venture Capital Lead investors
▥
Company - Funded company

▥ Classifications

industries
No industries detected
applications
No applications detected

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies